Search for other papers by Ladan Younesi in
Google Scholar
PubMed
Search for other papers by Zeinab Safarpour Lima in
Google Scholar
PubMed
Search for other papers by Azadeh Akbari Sene in
Google Scholar
PubMed
Search for other papers by Zahra Hosseini Jebelli in
Google Scholar
PubMed
Search for other papers by Ghazaleh Amjad in
Google Scholar
PubMed
Introduction Polycystic ovarian syndrome (PCOS) is one of the most common endocrinopathies in humans, which affects five to ten percent of women in childbearing age ( 1 ). About 20 to 30 percent of women in reproductive age show polycystic
Search for other papers by Gunjan Garg in
Google Scholar
PubMed
Search for other papers by Garima Kachhawa in
Google Scholar
PubMed
Search for other papers by Rekha Ramot in
Google Scholar
PubMed
Search for other papers by Rajesh Khadgawat in
Google Scholar
PubMed
Search for other papers by Nikhil Tandon in
Google Scholar
PubMed
Search for other papers by V Sreenivas in
Google Scholar
PubMed
Search for other papers by Alka Kriplani in
Google Scholar
PubMed
Search for other papers by N Gupta in
Google Scholar
PubMed
(OH)D level further inhibit the application of vitamin D intervention trials. Polycystic ovarian syndrome (PCOS) is now recognized as one of the most common endocrinopathies in women of reproductive age with a prevalence of 4–10% (9) . Women with PCOS
Search for other papers by Liza Haqq in
Google Scholar
PubMed
Search for other papers by James McFarlane in
Google Scholar
PubMed
Search for other papers by Gudrun Dieberg in
Google Scholar
PubMed
Search for other papers by Neil Smart in
Google Scholar
PubMed
Introduction Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine disorder, affecting 18–22% of reproductive-age women (1) . PCOS was first reported in 1935 by Stein & Leventhal (2) and is characterised by clinical or biochemical
Search for other papers by Line K Johnson in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Kirsten B Holven in
Google Scholar
PubMed
Search for other papers by Njord Nordstrand in
Google Scholar
PubMed
Search for other papers by Jan R Mellembakken in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Tom Tanbo in
Google Scholar
PubMed
Morbid Obesity Centre, Department of Nutrition, Norwegian National Advisory Unit on Familial Hypercholesterolemia, Department of Gynecology, Institute of Clinical Medicine, Department of Endocrinology, Vestfold Hospital Trust, PO Box 2168, 3103 Tønsberg, Norway
Search for other papers by Jøran Hjelmesæth in
Google Scholar
PubMed
Introduction Women with polycystic ovarian syndrome (PCOS) are often overweight and have a central fat distribution (1) . It is well known that abdominal obesity is associated with insulin resistance, metabolic syndrome (MS) and increased risk of
Search for other papers by Rosalie Cabry in
Google Scholar
PubMed
Search for other papers by Philippe Merviel in
Google Scholar
PubMed
Search for other papers by Aicha Madkour in
Google Scholar
PubMed
Search for other papers by Elodie Lefranc in
Google Scholar
PubMed
Search for other papers by Florence Scheffler in
Google Scholar
PubMed
Search for other papers by Rachel Desailloud in
Google Scholar
PubMed
Search for other papers by Véronique Bach in
Google Scholar
PubMed
Search for other papers by Moncef Benkhalifa in
Google Scholar
PubMed
use (especially in an occupational setting) on female reproductive capacity and certain female infertility diseases, such as premature ovarian failure (POF), polycystic ovarian syndrome (PCOS), and endometriosis. Furthermore, pesticide exposure might
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Philippos Edimiris in
Google Scholar
PubMed
Search for other papers by Laura Koch in
Google Scholar
PubMed
Search for other papers by Antje Enekwe in
Google Scholar
PubMed
Search for other papers by Claudia Lamina in
Google Scholar
PubMed
Search for other papers by Sabine Kasimir-Bauer in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Department of Gynecology and Obstetrics, Division of Genetic Epidemiology, Vitateq Biotechnology GmbH, University of Duisburg-Essen, D-45122 Essen, Germany
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
.3275/7682 ). 8 Baillargeon JP Nestler JE . Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin? Journal of Clinical Endocrinology and Metabolism 2006 91 22 – 24 . ( doi:10.1210/jc.2005-1804 ). 9 Dunaif A Segal
Search for other papers by Charissa van Zwol-Janssens in
Google Scholar
PubMed
Search for other papers by Aglaia Hage in
Google Scholar
PubMed
Search for other papers by Kim van der Ham in
Google Scholar
PubMed
Search for other papers by Birgitta K Velthuis in
Google Scholar
PubMed
Search for other papers by Ricardo P J Budde in
Google Scholar
PubMed
Search for other papers by Maria P H Koster in
Google Scholar
PubMed
Search for other papers by Arie Franx in
Google Scholar
PubMed
Search for other papers by Bart C J M Fauser in
Google Scholar
PubMed
Search for other papers by Eric Boersma in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Daniel Bos in
Google Scholar
PubMed
Search for other papers by Joop S E Laven in
Google Scholar
PubMed
Search for other papers by Yvonne V Louwers in
Google Scholar
PubMed
Search for other papers by the CREW consortium in
Google Scholar
PubMed
Introduction Reproductive disorders, such as premature ovarian insufficiency (POI) and polycystic ovary syndrome (PCOS), are associated with hormonal and metabolic changes, which can impact changes in bone density (BD). Women with POI are at
Search for other papers by Xiying Zeng in
Google Scholar
PubMed
Search for other papers by Yinxiang Huang in
Google Scholar
PubMed
Search for other papers by Mulin Zhang in
Google Scholar
PubMed
Search for other papers by Yun Chen in
Google Scholar
PubMed
Search for other papers by Jiawen Ye in
Google Scholar
PubMed
Search for other papers by Yan Han in
Google Scholar
PubMed
Search for other papers by Danyan Ma in
Google Scholar
PubMed
Search for other papers by Xin Zheng in
Google Scholar
PubMed
Search for other papers by Xiaohong Yan in
Google Scholar
PubMed
Department of Endocrinology and Diabetes, The First Affiliated Hospital, Xiamen University, Xiamen, China
Fujian Province Key Laboratory of Diabetes Translational Medicine, Xiamen, China
Search for other papers by Changqin Liu in
Google Scholar
PubMed
Chiofalo F Ciuoli C Formichi C Selmi F Forleo R Neri O Vuolo G Paffetti P Pacini F . Bariatric surgery reduces serum anti-Mullerian hormone levels in obese women with and without polycystic ovarian syndrome . Obesity Surgery 2017 27 1750
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
Search for other papers by Christina Bothou in
Google Scholar
PubMed
Search for other papers by Justyna Kuliczkowska-Płaksej in
Google Scholar
PubMed
Search for other papers by Ralitsa Robeva in
Google Scholar
PubMed
Search for other papers by Andromahi Vryonidou in
Google Scholar
PubMed
Search for other papers by Jelica Bjekic Macut in
Google Scholar
PubMed
Search for other papers by Ioannis Androulakis in
Google Scholar
PubMed
Search for other papers by Milica Opalic in
Google Scholar
PubMed
Search for other papers by Zadalla Mouslech in
Google Scholar
PubMed
Search for other papers by Andrej Milewicz in
Google Scholar
PubMed
Search for other papers by Alessandra Gambineri in
Google Scholar
PubMed
Search for other papers by Dimitrios Panidis in
Google Scholar
PubMed
Search for other papers by Djuro Macut in
Google Scholar
PubMed
ovary syndrome . European Journal of Endocrinology 2015 172 79 – 88 . ( https://doi.org/10.1530/EJE-14-0600 ) 38 Gracelyn LJ Pushpagiri N . Prevalence of glucose tolerance test abnormalities in women with polycystic ovarian syndrome
Search for other papers by Hong Tang in
Google Scholar
PubMed
Search for other papers by Xiaomei Jiang in
Google Scholar
PubMed
Search for other papers by Yu Hua in
Google Scholar
PubMed
Search for other papers by Heyue Li in
Google Scholar
PubMed
Search for other papers by Chunlan Zhu in
Google Scholar
PubMed
Search for other papers by Xiaobai Hao in
Google Scholar
PubMed
Search for other papers by Minhui Yi in
Google Scholar
PubMed
Search for other papers by Linxia Li in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is an androgen disorder and ovarian dysfunction disease in women of reproductive age. PCOS is responsible for more than 90% of adult and adolescent hyperandrogenism ( 1 , 2 ). The pathogenesis of